Axelar AB is a Swedish biotech company founded in 2003. The company is developing insulin-like growth factor-1 (IGF-1) receptor inhibitors for the treatment of cancer and other diseases.
Looking for a particular Axelar AB employee's phone or email?
The Axelar AB annual revenue was $1 million in 2026.
1 people are employed at Axelar AB.
The NAICS codes for Axelar AB are [541, 5417, 54, 54171, 541713].
The SIC codes for Axelar AB are [87, 873].